Semaglutide and tirzepatide were first used to help type 2 diabetes patients regulate their blood-sugar levels.
But in the past three to four years, they started being prescribed as a weight-loss aide, leading to global shortages and counterfeit products.
Both are given as weekly injections via pre-filled pens self-administered into the upper arm, thigh or stomach.
And patients generally start on a low dose, which is gradually increased.
The drugs mimic the intestinal hormone glucagon-like peptide-1 (GLP-1), which is released after eating and typically makes people feel fuller.
Tirzepatide (Mounjaro) also affects the glucose-dependent insulinotropic polypeptide (GIP) hormone, which controls metabolism and helps regulate energy balance.
The first study into weight-loss drugs has found they can significantly improve heart health, with lower levels of heart attacks, stroke, heart failure and high blood pressure.
Regional tensions are mounting as the US-Iran war continues and a rising number of Israeli…
Available for over a yearRight now, research is gathering pace in revolutionising our understanding of…
The young people are campaigning for a new role to be established, similar to the…
Eimear, Pearse, Aoísha and Devyn from Ballycastle want to see a change in how women…
Tuesday is a big day in Washington DC, even by White House standards. Long-time Republican…
The morning-after pill, known as emergency contraception, external, is medication designed to prevent unwanted pregnancies.…